2025 Guidance -- First quarter GMV forecasted at $90 million to $96 million (down 2% to up 5%), net revenue at $21.7 million ...
Cell-free protein synthesis (CFPS) systems are a powerful platform with immense potential in fundamental research, biotechnology, and synthetic biology. Conventional prokaryotic CFPS systems, ...